When was Alex Therapeutics founded?
Alex Therapeutics was founded in 2018.
Where is Alex Therapeutics's headquarters?
Alex Therapeutics's headquarters is located at Birger Jarlsgatan 57C, Stockholm.
What is Alex Therapeutics's latest funding round?
Alex Therapeutics's latest funding round is Series A.
How much did Alex Therapeutics raise?
Alex Therapeutics raised a total of $4.44M.
Who are the investors of Alex Therapeutics?
Investors of Alex Therapeutics include Sweet Studio, Scale Capital, Hadean Ventures and Bonit Capital.
Who are Alex Therapeutics's competitors?
Competitors of Alex Therapeutics include CureApp and 4 more.
You May Also Like
Kwit is a mobile app game that uses cognitive and behavioral therapies and evidence-based smoking cessation scientific methods to help users quit smoking and fight the symptoms of withdrawal.
CureApp is a digital health company that offers a horizontal spread of medical apps for the treatment and management of a range of diseases, which allows patient treatment data to be obtained on a daily basis through mobile devices such as smartphones. This information is then analyzed using algorithms based on known medical information in order to provide personalized guidance for individual patients. Its apps exhibit therapeutic effects against nicotine addiction, NASH (non-alcoholic steatohepatitis remedy), diabetes, depression, and lung cancer. The firm serves clients operating in the healthcare sector. It was founded in 2014 and is based in Tokyo, Japan.
2Morrow is a digital health/digital therapeutic company focused on behaviors that cause chronic disease. The company delivers programs based on the work of respected researchers directly into the hands of people, whenever and wherever they need them via their smartphone.
Quit Genius develops a digital clinic that delivers a comprehensive Medication-Assisted Treatment program for multiple addictions. It partners with employers, health plans, PBMs, and individual members, to battle addiction in the workplace across the U.S. and the U.K. The company was founded in 2017 and is based in New York, New York.
Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. Click's smoking cessation program is currently available nationwide through a variety of payers, providers, and employers. Click Therapeutics was founded in 2012 and is based in New York, New York.
Pivot is a digital health company on a mission to use mobile technology, behavioral science, and clinical expertise to engage and empower. The company's Pivot combines wearable tech, clinical expertise, personal coaching, and behavioral science to help people quit smoking.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.